优化氧合可改善长期氧疗COPD患者日常活动功能:随机交叉试验
该双盲随机交叉试验纳入31例长期氧疗的COPD患者,比较自动滴定氧流量(目标SpO2 90-94%)与固定氧流量对日常活动能力的影响。自动滴定组GlittreADL测试时间中位数缩短38秒,SpO2达标时间比例从19%升至49%,呼吸困难评分降低。提示优化氧合可改善功能容量并减轻呼吸困难。
要点
- 自动滴定氧流量较固定流量缩短ADL测试时间中位数38秒。
- 自动滴定使SpO2达标时间比例从19%提高至49%。
- 自动滴定组呼吸困难BorgCR10评分中位数5 vs 6,优于固定流量。
核心结论
- 改善氧合并延长目标饱和度内时间可减轻COPD长期氧疗患者日常活动中的呼吸困难并提高功能容量。
研究设计与样本
- 双盲随机交叉试验,31例COPD长期氧疗患者,分别使用固定氧剂量和自动滴定氧流量(0-8 L/min,目标SpO2 90-94%)完成两项GlittreADL测试。
主要发现
- 自动滴定组ADL测试时间中位数(IQR)缩短38(12-73)秒,p<0.001。
- 自动滴定组测试期间氧流量中位数(IQR)为5.4(4.1-6.8)L/min,固定组为1.6(1.1-2.1)L/min,p<0.001。
- SpO2达标时间比例从19%增至49%,p=0.002。
- 呼吸困难BorgCR10评分中位数(IQR)自动滴定组5(3-7) vs 固定组6(4-8),p<0.001。
关键数值与推荐
- 自动滴定目标SpO2范围为90-94%,氧流量调节范围0-8 L/min。
- 纳入患者平均±SD年龄72.8±5.9岁,FEV1占预计值36.7±12.7%。
临床怎么用
- 对长期氧疗的COPD患者,在日常活动中采用闭环自动滴定维持SpO2 90-94%可能优于固定氧流量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Minimising hypoxaemia during submaximal walking tests has a positive effect on exercise capacity and dyspnoea in patients with chronic obstructive pulmonary disease (COPD) on long-term oxygen therapy (LTOT). However, the impact of optimising oxygenation during everyday tasks remains unexplored. Therefore, we investigated the effects of maintaining a target saturation on activities of daily living (ADL) using automated oxygen titration compared with conventional fixed oxygen flow. METHODS: In a double-blinded, randomised crossover trial, patients with COPD on LTOT performed two GlittreADL tests to assess the functional capacity of everyday activities using (1) their fixed oxygen dose and (2) an adjusted flow from 0 to 8 L/min targeting a peripheral oxygen saturation (SpO2) of 90-94%. A closed-loop device automatically titrated the oxygen based on information from a Bluetooth wrist pulse oximeter. RESULTS: 31 patients (mean±SD age: 72.8±5.9 years, forced expiratory volume in 1 s of % predicted: 36.7±12.7) were included. The patients reduced the time to perform the ADL test by median (IQR) 38 (12-73) s, p<0.001, using automated titration compared with the fixed oxygen flow. The oxygen flow in the automated arm more than tripled to 5.4 (4.1-6.8) versus 1.6 (1.1-2.1) L/min (fixed) during the test, p<0.001, while the time spent within SpO2-target was increased from 19% to 49%, p=0.002. Correspondingly, the patients experienced less dyspnoea (BorgCR10); 5 (3-7) versus 6 (4-8), p<0.001, in favour of the automated oxygen titration. CONCLUSIONS: Improving oxygenation and extending the time spent within target saturation reduced dyspnoea and improved functional capacity in ADL in patients with COPD on LTOT. TRIAL REGISTRATION NUMBER: NCT05553847.
引用
- Kofod LM, Hansen EF, Brocki BC, et al. Optimised oxygenation improves functional capacity during daily activities in patients with COPD on long-term oxygen therapy: a randomised crossover trial. Thorax. 2025. PMID: 40473413. doi:10.1136/thorax-2024-221883
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。